Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 36% ± 20% | |
ciliated cell | 7 studies | 27% ± 5% | |
retina horizontal cell | 6 studies | 46% ± 18% | |
retinal cone cell | 6 studies | 38% ± 11% | |
endothelial cell of lymphatic vessel | 6 studies | 36% ± 9% | |
retinal rod cell | 5 studies | 30% ± 13% | |
GABAergic neuron | 5 studies | 45% ± 20% | |
retinal bipolar neuron | 4 studies | 34% ± 11% | |
astrocyte | 4 studies | 26% ± 4% | |
interneuron | 4 studies | 52% ± 19% | |
epithelial cell | 3 studies | 57% ± 29% | |
OFF-bipolar cell | 3 studies | 51% ± 9% | |
amacrine cell | 3 studies | 44% ± 15% | |
rod bipolar cell | 3 studies | 54% ± 17% | |
goblet cell | 3 studies | 32% ± 18% | |
granule cell | 3 studies | 41% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 15994.73 | 653 / 653 | 95% | 10.30 | 572 / 605 |
kidney | 98% | 1514.96 | 87 / 89 | 84% | 3.67 | 757 / 901 |
brain | 97% | 5677.17 | 2553 / 2642 | 71% | 2.99 | 501 / 705 |
skin | 93% | 713.14 | 1681 / 1809 | 60% | 2.27 | 284 / 472 |
pancreas | 93% | 544.11 | 306 / 328 | 47% | 1.01 | 84 / 178 |
breast | 91% | 1095.71 | 418 / 459 | 45% | 1.27 | 504 / 1118 |
lung | 98% | 806.07 | 565 / 578 | 17% | 0.37 | 201 / 1155 |
prostate | 89% | 608.09 | 219 / 245 | 19% | 0.26 | 93 / 502 |
liver | 85% | 533.01 | 192 / 226 | 21% | 0.70 | 86 / 406 |
esophagus | 85% | 874.82 | 1222 / 1445 | 20% | 0.62 | 37 / 183 |
spleen | 98% | 775.47 | 235 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 1596.32 | 832 / 861 | 0% | 0 | 0 / 0 |
intestine | 70% | 446.31 | 678 / 966 | 25% | 0.52 | 131 / 527 |
uterus | 59% | 358.66 | 100 / 170 | 28% | 0.79 | 130 / 459 |
blood vessel | 82% | 852.39 | 1095 / 1335 | 0% | 0 | 0 / 0 |
adipose | 77% | 390.93 | 933 / 1204 | 0% | 0 | 0 / 0 |
bladder | 57% | 354.00 | 12 / 21 | 18% | 0.46 | 90 / 504 |
stomach | 52% | 231.30 | 188 / 359 | 21% | 0.52 | 60 / 286 |
eye | 0% | 0 | 0 / 0 | 57% | 2.00 | 46 / 80 |
tonsil | 0% | 0 | 0 / 0 | 38% | 0.66 | 17 / 45 |
muscle | 33% | 143.58 | 269 / 803 | 0% | 0 | 0 / 0 |
ovary | 17% | 63.58 | 30 / 180 | 12% | 0.24 | 52 / 430 |
adrenal gland | 10% | 45.93 | 25 / 258 | 11% | 0.32 | 25 / 230 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.08 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002098 | Biological process | tRNA wobble uridine modification |
GO_0006400 | Biological process | tRNA modification |
GO_0030488 | Biological process | tRNA methylation |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000049 | Molecular function | tRNA binding |
GO_0008175 | Molecular function | tRNA methyltransferase activity |
GO_0008757 | Molecular function | S-adenosylmethionine-dependent methyltransferase activity |
GO_0106335 | Molecular function | tRNA (5-carboxymethyluridine(34)-5-O)-methyltransferase activity |
Gene name | TRMT9B |
Protein name | Probable tRNA methyltransferase 9B (Probable tRNA methyltransferase 9-like protein) (EC 2.1.1.-) tRNA methyltransferase 9B (putative) |
Synonyms | C8orf79 TRM9L KIAA1456 |
Description | FUNCTION: May modify wobble uridines in specific arginine and glutamic acid tRNAs. Acts as a tumor suppressor by promoting the expression of LIN9. . |
Accessions | ENST00000528753.2 [Q9P272-3] F6XBY7 ENST00000524591.7 [Q9P272-1] ENST00000532376.2 E9PK20 ENST00000447063.6 Q9P272 ENST00000400069.7 [Q9P272-3] |